ABOT Stock Overview
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Abbott Laboratories (Pakistan) Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨669.26 |
| 52 Week High | PK₨690.00 |
| 52 Week Low | PK₨330.00 |
| Beta | 0.66 |
| 1 Month Change | 22.13% |
| 3 Month Change | 61.64% |
| 1 Year Change | 67.56% |
| 3 Year Change | -13.25% |
| 5 Year Change | 44.08% |
| Change since IPO | 1,671.83% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABOT | PK Pharmaceuticals | PK Market | |
|---|---|---|---|
| 7D | 4.3% | 1.7% | 2.6% |
| 1Y | 67.6% | 64.0% | 59.5% |
Return vs Industry: ABOT exceeded the PK Pharmaceuticals industry which returned 64% over the past year.
Return vs Market: ABOT exceeded the PK Market which returned 59.4% over the past year.
Price Volatility
| ABOT volatility | |
|---|---|
| ABOT Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PK Market | 7.8% |
| 10% least volatile stocks in PK Market | 3.3% |
Stable Share Price: ABOT's share price has been volatile over the past 3 months.
Volatility Over Time: ABOT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1888 | 1,430 | Syed Ahmed | www.pk.abbott |
Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company offers portfolio of products in various therapeutic areas, including women’s and men’s health, gastroenterology, central nervous system, pediatrics, vitamins, cardiometabolic and metabolic, pain and fever, respiratory, and hospital care.
Abbott Laboratories (Pakistan) Limited Fundamentals Summary
| ABOT fundamental statistics | |
|---|---|
| Market cap | PK₨65.52b |
| Earnings (TTM) | PK₨2.00b |
| Revenue (TTM) | PK₨57.70b |
32.8x
P/E Ratio1.1x
P/S RatioIs ABOT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABOT income statement (TTM) | |
|---|---|
| Revenue | PK₨57.70b |
| Cost of Revenue | PK₨44.69b |
| Gross Profit | PK₨13.00b |
| Other Expenses | PK₨11.00b |
| Earnings | PK₨2.00b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 20.43 |
| Gross Margin | 22.54% |
| Net Profit Margin | 3.47% |
| Debt/Equity Ratio | 0% |
How did ABOT perform over the long term?
See historical performance and comparison